SCHEMBL5082472

SCHEMBL5082472

OCCN1CCNCC1CCCN1c2ccccc2Sc2ccc(Cl)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.61
MAPT P10636 6/20 0.61
DRD2 P14416 5/20 0.61
CYP2C19 P33261 5/20 0.61
LMNA P02545 5/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
MAPK1 P28482 5/20 0.61
ADRA2A P08913 4/20 0.61
ADRA2B P18089 4/20 0.61
ADRA2C P18825 4/20 0.61
SLC6A2 P23975 4/20 0.61
HTR2A P28223 4/20 0.61
HTR2C P28335 4/20 0.61
SLC6A4 P31645 4/20 0.61
HRH1 P35367 4/20 0.61
DRD3 P35462 4/20 0.61
HTR2B P41595 4/20 0.61
CYP1A2 P05177 4/20 0.61
HTR1A P08908 4/20 0.61
TP53 P04637 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3441267 0.99 CYP2D6 (0.60) CYP2D6MAPTDRD2CYP2C19LMNA
SCHEMBL6637375 0.77 LMNA (0.74) CYP2D6MAPTDRD2CYP2C19LMNA
SCHEMBL30030635 0.76 KDM1A (0.79) CYP2D6MAPTDRD2CYP2C19LMNA
SCHEMBL18752072 0.76 KDM1A (0.79) CYP2D6MAPTDRD2CYP2C19LMNA
Perphenazine SCHEMBL29385591 0.76 MAPT (1.00) CYP2D6MAPTDRD2CYP2C19LMNA
Perphenazine SCHEMBL29461866 0.76 MAPT (1.00) CYP2D6MAPTDRD2CYP2C19LMNA
Perphenazine SCHEMBL42125 0.76 MAPT (1.00) CYP2D6MAPTDRD2CYP2C19LMNA
Perphenazine SCHEMBL8762197 0.76 MAPT (1.00) CYP2D6MAPTDRD2CYP2C19LMNA
SCHEMBL5082482 0.76 CYP2D6 (0.59) CYP2D6MAPTDRD2CYP2C19LMNA
SCHEMBL6045312 0.76 PIM1 (0.56) CYP2D6MAPTDRD2CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956906-A2 METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS CombinatoRx, Incorporated (US) 2008-08-20 EP disclosed
WO-2007056457-A2 METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS COMBINATORX, INCORPORATED (US) 2007-05-18 WO disclosed